Genetic polymorphisms of the CYP2E1 gene do not contribute to oral cancer susceptibility in south Indians

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 6, 2011, Pages 1523-1527

  Balaji, Lakshmi ^a   Singh, Krishna Balaji ^a   Bhaskar, L V K S ^a  

^a SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Alleles; CYP2E1; Haplotypes; Oral cancer

Indexed keywords

EID: 84858042433     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Barrett JC, Fry B, Maller J, et al (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics, 21,263-5.
2. Bouchardy C, Hirvonen A, Coutelle C, et al (2000). Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer, 87, 734-40.
3. Buch SC, Nazar-Stewart V, Weissfeld JL, et al (2008). Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes. Head Neck, 30, 1139-47.
4. Carriere V, Berthou F, Baird S, et al (1996). Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics, 6, 203-11.
5. Chen JM, Ferec C, Cooper DN. (2006). A systematic analysis of disease-associated variants in the 3' regulatory regions of human protein-coding genes I: general principles and overview. Hum Genet, 120,1-21.
6. Cubells JF, Kobayashi K, Nagatsu T, et al (1997). Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet, 74, 374-9.
7. Garte S, Gaspari L, Alexandrie AK, et al (2001). Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev, 10, 1239-48.
8. Gattas GJ, de Carvalho MB, Siraque MS, et al (2006). Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck, 28, 819-26.
9. Guengerich FP, Kim DH, Iwasaki M. (1991). Role of human cytochrome P-450 IIE1 in the oxidation of many low molecular weight cancer suspects. Chem Res Toxicol, 4, 168-79.
10. Hata S, Miki Y, Fujishima F, et al (2010). Cytochrome 3A and 2E1 in human liver tissue: Individual variations among normal Japanese subjects. Life Sci, 86, 393-401.
11. Hayashi S, Watanabe J, Kawajiri K. (1991). Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem, 110,559-65.
12. Hildesheim A, Chen CJ, Caporaso NE, et al (1995). Cytochrome P4502E1 genetic polymorphisms and risk of nasopharyngeal carcinoma: results from a case-control study conducted in Taiwan. Cancer Epidemiol Biomarkers Prev, 4, 607-10.
13. Howard LA, Miksys S, Hoffmann E, et al (2003). Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. Br J Pharmacol, 138, 1376-86.
14. Jhavar S, Sarin R, Mulherkar R, et al (2004). Glutathione S-transferase M1 or T1 null genotype as a risk factor for developing multiple primary neoplasms in the upper aero-digestive tract, in Indian males using tobacco. Oral Oncol, 40, 84-91.
15. Kato S, Shields PG, Caporaso NE, et al (1992). Cytochrome P450IIE1 genetic polymorphisms, racial variation, and lung cancer risk. Cancer Res, 52, 6712-5.
16. Kidd KK, Morar B, Castiglione CM, et al (1998). A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Hum Genet, 103, 211-27.
17. Klinchid J, Chewaskulyoung B, Saeteng S, et al (2009). Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women. Cancer Genet Cytogenet, 195, 143-9.
18. Lee MY, Mukherjee N, Pakstis AJ, et al (2008). Global patterns of variation in allele and haplotype frequencies and linkage disequilibrium across the CYP2E1 gene. Pharmacogenomics J, 8, 349-56.
19. Lewis DF, Bird MG, Parke DV. (1997). Molecular modelling of CYP2E1 enzymes from rat, mouse and man: an explanation for species differences in butadiene metabolism and potential carcinogenicity, and rationalization of CYP2E substrate specificity. Toxicology, 118, 93-113.
20. Lieber CS. (1997). Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev, 77, 517-44.
21. Liu S, Park JY, Schantz SP, et al (2001). Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol, 37, 437-45.
22. Liu TY, Chung YT, Wang PF, et al (2004). Safrole-DNA adducts in human peripheral blood--an association with areca quid chewing and CYP2E1 polymorphisms. Mutat Res, 559, 59-66.
23. London SJ, Daly AK, Cooper J, et al (1996). Lung cancer risk in relation to the CYP2E1 Rsa I genetic polymorphism among African-Americans and Caucasians in Los Angeles County. Pharmacogenetics, 6, 151-8.
24. Marques CF, Koifman S, Koifman RJ, et al (2006). Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. Oral Oncol, 42, 632-7.
25. Matthias C, Jahnke V, Fryer AA, et al (2002). Influence of glutathione s-transferase and cytochrome p450 polymorphisms on prognosis of head and neck cancer. Laryngorhinootologie, 81, 406-12.
26. Mueller RL, Hagel HJ, Wild H, et al (1986). Nitrate and nitrite in normal gastric juice. Precursors of the endogenous N-nitroso compound synthesis. Oncology, 43,5 0-3.
27. Rendic S. (2002). Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev, 34, 83-448.
28. Rendic S, Guengerich FP. (2010). Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Curr Drug Metab, 11,4-84.
29. Sambrook J, Fitsch EF, Maniatis T. (1989). Molecular Cloning: A Laboratory Manual. Cold Spring Harbor: Cold Spring Harbor Press.
30. Seitz HK, Stickel F. (2007). Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer, 7, 599-612.
31. Sikdar N, Mahmud SA, Paul RR, et al (2003). Polymorphism in CYP1A1 and CYP2E1 genes and susceptibility to leukoplakia in Indian tobacco users. Cancer Lett, 195, 33-42.
32. Soya SS, Vinod T, Reddy KS, et al (2008). CYP2E1 polymorphisms and gene-environment interactions in the risk of upper aerodigestive tract cancers among Indians. Pharmacogenomics, 9, 551-60.
33. Sugimura T, Kumimoto H, Tohnai I, et al (2006). Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med, 35, 11-18.
34. Tan W, Song N, Wang GQ, et al (2000). Impact of genetic polymorphisms in cytochrome P450 2E1 and glutathione S-transferases M1, T1, and P1 on susceptibility to esophageal cancer among high-risk individuals in China. Cancer Epidemiol Biomarkers Prev, 9, 551-6.
35. Tang K, Li Y, Zhang Z, et al (2010). The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies. BMC Cancer, 10, 575.
36. Wang Y, Yang H, Li L, et al (2010). Association between CYP2E1 genetic polymorphisms and lung cancer risk: a meta-analysis. Eur J Cancer, 46, 758-64.
37. Wu X, Shi H, Jiang H, et al (1997). Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis, 18, 967-73.
38. Ye X, Peng T, Liu T, et al (2010). Association between aldehyde dehydrogenase-2/cytochrome P450 2E1 genetic polymorphism and habit of alcohol drinking and the susceptibility of hepatocellular carcinoma. Wei Sheng Yan Jiu, 39, 42-5 (in Chinese).
39. Yue J, Khokhar J, Miksys S, et al (2009). Differential induction of ethanol-metabolizing CYP2E1 and nicotine-metabolizing CYP2B1/2 in rat liver by chronic nicotine treatment and voluntary ethanol intake. Eur J Pharmacol, 609, 88-95.
40. Zavras AI, Wu T, Laskaris G, et al (2002). Interaction between a single nucleotide polymorphism in the alcohol dehydrogenase 3 gene, alcohol consumption and oral cancer risk. Int J Cancer, 97, 526-30.